Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome Clinical Trial

Official title: Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome: A Randomized, Double-blinded,Placebo- Controlled Multicenter Study

Status Not yet recruiting

Clinical Trial Summary

Clostridium Butyricum might be an effective drug in treating irritable bowel syndrome

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
• Irritable Bowel Syndrome
• Syndrome

• NCT number: NCT02614963
• Study type: Interventional
• Source: Shandong University
• Contact: Li Yanqing, MD,PhD
• Phone: 86-531-82169236
• Email: liyanqing@sdu.edu.cn
• Status: Not yet recruiting
• Phase: Phase 4
• Start date: December 2015
• Completion date: July 2016